These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 2224694)

  • 1. Zidovudine (Retrovir) update.
    Rachlis AR
    CMAJ; 1990 Dec; 143(11):1177-85. PubMed ID: 2224694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic effects of zidovudine in asymptomatic human immunodeficiency virus-infected individuals with CD4+ cell counts of 0.50 x 10(9)/L or less. Detailed and updated results from protocol 019 of the AIDS Clinical Trials Group.
    Koch MA; Volberding PA; Lagakos SW; Booth DK; Pettinelli C; Myers MW
    Arch Intern Med; 1992 Nov; 152(11):2286-92. PubMed ID: 1359846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)].
    Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Iribarren JA; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P
    Enferm Infecc Microbiol Clin; 2000; 18(7):329-51. PubMed ID: 11109725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-retroviral therapy of HIV-infection. With preliminary results of the Swiss postmarketing surveillance of zidovudine].
    Jost J; Lüthy R
    Schweiz Med Wochenschr; 1991 Apr; 121(16):555-65. PubMed ID: 1904164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of treatment with AZT of patients with AIDS and symptomatic HIV infection.
    Cox PH; Martin MA; Styer CM; Beall GN
    Nurse Pract; 1990 May; 15(5):36, 39-44. PubMed ID: 2342666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zidovudine for the treatment of HIV infection.
    Pepe R; Molavi A
    Am Fam Physician; 1990 Aug; 42(2):437-43. PubMed ID: 2200250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group.
    Lenderking WR; Gelber RD; Cotton DJ; Cole BF; Goldhirsch A; Volberding PA; Testa MA
    N Engl J Med; 1994 Mar; 330(11):738-43. PubMed ID: 7906386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recommendations of GESIDA (Grupo de Estudio de SIDA)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (II)].
    Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Antonio Iribarren J; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P;
    Enferm Infecc Microbiol Clin; 2000 Oct; 18(8):396-412. PubMed ID: 11153204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early intervention in HIV infection].
    Gotić M; Rolović Z; Elezović I; Marisavljević D; Berger D
    Srp Arh Celok Lek; 1992 Nov; 120 Suppl 5():30-2. PubMed ID: 18170974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiretroviral therapy in Switzerland 1991].
    Hirschel B; Vanhems P
    Schweiz Med Wochenschr; 1991 Aug; 121(34):1187-93. PubMed ID: 1925447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of HIV infection in adults.
    Harrington PT
    J Fla Med Assoc; 1991 Oct; 78(10):664-8. PubMed ID: 1753230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term zidovudine therapy in patients with AIDS and symptomatic and asymptomatic HIV infection.
    Ebert S; Gockel K; Horowitz S; Weber P; Vogelman B; Graziano F
    Wis Med J; 1991 Apr; 90(4):161-5. PubMed ID: 1675028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex.
    Schmitt FA; Bigley JW; McKinnis R; Logue PE; Evans RW; Drucker JL
    N Engl J Med; 1988 Dec; 319(24):1573-8. PubMed ID: 3059187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-macrophage colony-stimulating factor and zidovudine in the treatment of neutropenia and human immunodeficiency virus infection.
    Hewitt RG; Morse GD
    Pharmacotherapy; 1992; 12(6):455-61. PubMed ID: 1492010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Wilde MI; Langtry HD
    Drugs; 1993 Sep; 46(3):515-578. PubMed ID: 7693435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zidovudine (AZT) for treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice.
    Colson ER; Horwitz RI; Bia FJ; Viscoli CM
    Arch Intern Med; 1991 Apr; 151(4):709-13. PubMed ID: 2012453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.